No abstract available
Keywords:
Angiotensin receptor blocker (ARB); Angiotensin-converting enzyme inhibitor (ACEI); Coronavirus disease 2019 (COVID-19); Hypertention; Outcome; Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Angiotensin Receptor Antagonists / adverse effects
-
Angiotensin Receptor Antagonists / therapeutic use*
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
COVID-19 / epidemiology*
-
COVID-19 Drug Treatment
-
China
-
Female
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / epidemiology
-
Male
-
Middle Aged
-
SARS-CoV-2
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors